PROCEPT BioRobotics Corporation : Technically solid

07/01/2022 | 03:40am EDT

Nicolas Aleksy

long trade Target price hit

Entry price : 32.17$ | Target : 43$ | Stop-loss : 24.9$ | Potential : 33.66%

Shares in PROCEPT BioRobotics Corporation do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend. Investors have an opportunity to buy the stock and target the $ 43.

Summary

• From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

• The prospective high growth for the next fiscal years is among the main assets of the company
• Thanks to a sound financial situation, the firm has significant leeway for investment.
• Over the past year, analysts have regularly revised upwards their sales forecast for the company.
• Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
• Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
• The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
• The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

• The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
• The company has insufficient levels of profitability.
• The company's "enterprise value to sales" ratio is among the highest in the world.
• The average consensus view of analysts covering the stock has deteriorated over the past four months.
• Over the past twelve months, analysts' consensus has been significantly revised downwards.

© MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.